FI763308A - - Google Patents

Info

Publication number
FI763308A
FI763308A FI763308A FI763308A FI763308A FI 763308 A FI763308 A FI 763308A FI 763308 A FI763308 A FI 763308A FI 763308 A FI763308 A FI 763308A FI 763308 A FI763308 A FI 763308A
Authority
FI
Finland
Application number
FI763308A
Other languages
Finnish (fi)
Other versions
FI62306B (en
FI62306C (en
Inventor
Burton Grant Christensen
William Joseph Leanza
Kenneth James Wildonger
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI763308A publication Critical patent/FI763308A/fi
Priority to FI821262A priority Critical patent/FI63030C/en
Publication of FI62306B publication Critical patent/FI62306B/en
Application granted granted Critical
Publication of FI62306C publication Critical patent/FI62306C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI763308A 1975-11-21 1976-11-18 FOERFARANDE FOER FRAMSTAELLNING AV SUBSTITUERADE N-METYLEN-DERIVAT AV TIENAMYCIN ANVAENDBARA SAOSOM ANTIBIOTISKA AEMNEN FI62306C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI821262A FI63030C (en) 1975-11-21 1982-04-08 FOERFARANDE FOER FRAMSTAELLNING AV SOM ANTIBIOTER ANVAENDBARA SUBSTITUERADE N-METYLENDERIVAT AV TIENAMYCIN

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US63429675A 1975-11-21 1975-11-21
US63429675 1975-11-21
US67626176A 1976-04-12 1976-04-12
US67626176 1976-04-12
US73365476A 1976-10-18 1976-10-18
US73365476 1976-10-18

Publications (3)

Publication Number Publication Date
FI763308A true FI763308A (en) 1977-05-22
FI62306B FI62306B (en) 1982-08-31
FI62306C FI62306C (en) 1982-12-10

Family

ID=27417545

Family Applications (1)

Application Number Title Priority Date Filing Date
FI763308A FI62306C (en) 1975-11-21 1976-11-18 FOERFARANDE FOER FRAMSTAELLNING AV SUBSTITUERADE N-METYLEN-DERIVAT AV TIENAMYCIN ANVAENDBARA SAOSOM ANTIBIOTISKA AEMNEN

Country Status (27)

Country Link
AT (1) AT358168B (en)
AU (1) AU512383B2 (en)
BG (1) BG34037A3 (en)
CA (1) CA1083577A (en)
CH (2) CH632510A5 (en)
DD (1) DD127742A5 (en)
DE (1) DE2652679A1 (en)
DK (1) DK157401C (en)
EG (1) EG12261A (en)
ES (1) ES453501A1 (en)
FI (1) FI62306C (en)
FR (1) FR2332012A1 (en)
GB (1) GB1570990A (en)
GR (1) GR62072B (en)
HK (1) HK29683A (en)
HU (1) HU180865B (en)
IE (1) IE44433B1 (en)
IL (1) IL50911A (en)
KE (1) KE3286A (en)
NL (1) NL189297C (en)
NO (1) NO153298C (en)
NZ (1) NZ182630A (en)
PH (1) PH16714A (en)
PL (1) PL110937B1 (en)
PT (1) PT65865B (en)
SE (1) SE427841B (en)
SG (1) SG10983G (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
SE436569B (en) * 1977-05-05 1985-01-07 Merck & Co Inc ANALOGY PROCEDURE FOR THE PREPARATION OF TIENAMYCIN DERIVATIVES
US4232030A (en) * 1977-09-15 1980-11-04 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone
DK153486C (en) * 1978-07-03 1988-11-28 Merck & Co Inc ANALOGY PROCEDURE FOR THE PREPARATION OF CRYSTALLINIC N-FORMIMIDOYL-THIENAMYCINE MONOHYDRATE
EP0044170A1 (en) * 1980-07-11 1982-01-20 Beecham Group Plc Beta-lactam antibiotics, their preparation and use
CA2089261A1 (en) * 1990-08-30 1992-03-01 John F.W. Keana Substituted amidines having high binding to the sigma receptor and the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1004670A (en) * 1963-04-23 1965-09-15 Beecham Res Lab Penicillins
GB1348984A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Antibiotics and processes for their production
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics

Also Published As

Publication number Publication date
NO763958L (en) 1977-05-24
NL189297B (en) 1992-10-01
DE2652679C2 (en) 1990-03-01
DK157401B (en) 1990-01-02
EG12261A (en) 1978-12-31
IE44433L (en) 1977-05-21
AT358168B (en) 1980-08-25
PT65865A (en) 1976-12-01
NL7612939A (en) 1977-05-24
NO153298B (en) 1985-11-11
IL50911A (en) 1981-01-30
DE2652679A1 (en) 1977-06-02
IE44433B1 (en) 1981-12-02
HK29683A (en) 1983-08-26
NO153298C (en) 1986-02-19
FR2332012B1 (en) 1978-11-17
SE7612963L (en) 1977-05-22
PT65865B (en) 1978-10-12
ATA863476A (en) 1980-01-15
PH16714A (en) 1984-01-25
SG10983G (en) 1983-12-16
FI62306B (en) 1982-08-31
GR62072B (en) 1979-02-20
AU1964776A (en) 1978-05-25
BG34037A3 (en) 1983-06-15
DD127742A5 (en) 1977-10-12
CH633800A5 (en) 1982-12-31
AU512383B2 (en) 1980-10-09
GB1570990A (en) 1980-07-09
NZ182630A (en) 1979-07-11
IL50911A0 (en) 1977-01-31
SE427841B (en) 1983-05-09
PL193809A1 (en) 1978-01-16
DK523576A (en) 1977-05-22
DK157401C (en) 1990-05-21
CH632510A5 (en) 1982-10-15
FI62306C (en) 1982-12-10
ES453501A1 (en) 1978-03-01
NL189297C (en) 1993-03-01
CA1083577A (en) 1980-08-12
KE3286A (en) 1983-06-17
FR2332012A1 (en) 1977-06-17
PL110937B1 (en) 1980-08-30
HU180865B (en) 1983-04-29

Similar Documents

Publication Publication Date Title
FR2308662B1 (en)
FI761045A (en)
FR2332012B1 (en)
JPS5253397U (en)
JPS5226510U (en)
JPS5240200U (en)
JPS5613462Y2 (en)
JPS5215009U (en)
JPS5338859Y2 (en)
JPS523701U (en)
JPS5259056U (en)
CH599157A5 (en)
CH592193A5 (en)
CH598003A5 (en)
CH597845A5 (en)
CH597769A5 (en)
CH604423A5 (en)
CH597602A5 (en)
CH597390A5 (en)
CH598678A5 (en)
CH597016A5 (en)
CH596528A5 (en)
CH596178A5 (en)
CH595183A5 (en)
CH594888A5 (en)

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: MERCK & CO., INC.